Related references
Note: Only part of the references are listed.Neuroinflammation and depression: A review
Romain Troubat et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2021)
Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment
Ashley N. Siegel et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial
Mostafa Farajollahi-Moghadam et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2021)
Phosphodiesterase-5 inhibitors: Shedding new light on the darkness of depression?
Eduardo Duarte-Silva et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Role of oxidative stress in depression
Shvetank Bhatt et al.
DRUG DISCOVERY TODAY (2020)
The association between self-reported health status and adverse events: a comparison among coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI)
Stine Norris Nielsen et al.
QUALITY OF LIFE RESEARCH (2020)
Role of Myocardial Infarction-Induced Neuroinflammation for Depression-Like Behavior and Heart Failure in Ovariectomized Female Rats
Fatimah Najjar et al.
NEUROSCIENCE (2019)
Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials
O. Kohler-Forsherg et al.
ACTA PSYCHIATRICA SCANDINAVICA (2019)
Relating the blood-thinning effect of pentoxifylline to the reduction in the elastic modulus of human red blood cells: an in vivo study
Katerina E. Aifantis et al.
BIOMATERIALS SCIENCE (2019)
Insights into the potential antidepressant mechanisms of cilostazol in chronically restraint rats: impact on the Nrf2 pathway
Sally A. Abuelezz et al.
BEHAVIOURAL PHARMACOLOGY (2018)
The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
Sahar Mohamed El-Haggar et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2018)
Depression and coronary heart disease
Robert M. Carney et al.
NATURE REVIEWS CARDIOLOGY (2017)
Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials
Daniel Brie et al.
JOURNAL OF HYPERTENSION (2016)
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
D. R. Goldsmith et al.
MOLECULAR PSYCHIATRY (2016)
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman et al.
NATURE MEDICINE (2016)
Pentoxifylline for vascular health: a brief review of the literature
Mark F. McCarty et al.
OPEN HEART (2016)
Pentoxifylline in Heart Failure: A Meta-Analysis of Clinical Trials
Sebastien Champion et al.
CARDIOVASCULAR THERAPEUTICS (2014)
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients
Nazila Shahmansouri et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study
Danial Khajavi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Pretreatment with pentoxifylline has antidepressant-like effects in a rat model of acute myocardial infarction
Thierno Madjou Bah et al.
BEHAVIOURAL PHARMACOLOGY (2011)
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research
Anna Meijer et al.
GENERAL HOSPITAL PSYCHIATRY (2011)
Depressive symptoms, physical inactivity and risk of cardiovascular mortality in older adults: the Cardiovascular Health Study
Sithu Win et al.
HEART (2011)
Dementia and Depression with Ischemic Heart Disease: A Population-Based Longitudinal Study Comparing Interventional Approaches to Medical Management
W. Alan C. Mutch et al.
PLOS ONE (2011)
Depression and heart rate variability in patients with coronary heart disease
R. M. CARNEY et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)
Antidepressant- and Anxiolytic-like Effects of the Phosphodiesterase-4 Inhibitor Rolipram on Behavior Depend on Cyclic AMP Response Element Binding Protein-Mediated Neurogenesis in the Hippocampus
Yun-Feng Li et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease - A randomized placebo-controlled study
Juliano Lara Fernandes et al.
ATHEROSCLEROSIS (2008)
Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial
Shahrokh Amiri et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Nonresponse to treatment for depression following myocardial infarction: Association with subsequent cardiac events
Peter de Jonge et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Course of depressive symptoms and medication adherence after acute coronary syndromes -: An electronic medication monitoring study
Nina Rieckmann et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Pentoxifylline affects cytokine reaction in cardiopulmonary bypass
Ihsan Iskesen et al.
HEART SURGERY FORUM (2006)
Depression in heart failure - A meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes
Thomas Rutledge et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Impairment of endothelial function in unipolar and bipolar depression
Janusz K. Rybakowski et al.
BIOLOGICAL PSYCHIATRY (2006)
Prevalence of depression in survivors of acute myocardial infarction - Review of the evidence
BD Thombs et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2006)
Cardiovascular side effects of new antidepressants and antipsychotics: New drugs, old concerns?
P Pacher et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis
JP van Melle et al.
PSYCHOSOMATIC MEDICINE (2004)
Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction
MV Pitzalis et al.
AMERICAN HEART JOURNAL (2001)
Effects of the non-selective phosphodiesterase inhibitor pentoxifylline on regional cerebral blood flow and large arteries in healthy subjects
C Krusse et al.
EUROPEAN JOURNAL OF NEUROLOGY (2000)